Cite
PCV103 - MANAGEMENT OF ATHEROGENIC DYSLIPIDEMIA IN REAL CLINICAL PRACTICE WITHIN THE SPANISH HEALTH SYSTEM ACCORDING TO CURRENT TREATMENT GUIDELINES: DESPEGA STUDY
MLA
J.M. Millán, et al. “Pcv103 - Management of Atherogenic Dyslipidemia in Real Clinical Practice within the Spanish Health System According to Current Treatment Guidelines: Despega Study.” Value in Health, vol. 21, Oct. 2018, pp. S109–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........aed4a5c132275cd0fa60ade43ece04d5&authtype=sso&custid=ns315887.
APA
J.M. Millán, Paulino Pérez Rodríguez, M. Melogno Klinkas, M.L. Orera Peña, Susana Aceituno, & M. Rodríguez de Miguel. (2018). Pcv103 - Management of Atherogenic Dyslipidemia in Real Clinical Practice within the Spanish Health System According to Current Treatment Guidelines: Despega Study. Value in Health, 21, S109–S110.
Chicago
J.M. Millán, Paulino Pérez Rodríguez, M. Melogno Klinkas, M.L. Orera Peña, Susana Aceituno, and M. Rodríguez de Miguel. 2018. “Pcv103 - Management of Atherogenic Dyslipidemia in Real Clinical Practice within the Spanish Health System According to Current Treatment Guidelines: Despega Study.” Value in Health 21 (October): S109–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........aed4a5c132275cd0fa60ade43ece04d5&authtype=sso&custid=ns315887.